Syngene International Limited
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and anal… Read more
Syngene International Limited (SYNGENE) - Total Assets
Latest total assets as of September 2025: ₹65.42 Billion INR
Based on the latest financial reports, Syngene International Limited (SYNGENE) holds total assets worth ₹65.42 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Syngene International Limited - Total Assets Trend (2010–2025)
This chart illustrates how Syngene International Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Syngene International Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Syngene International Limited's total assets of ₹65.42 Billion consist of 33.7% current assets and 66.3% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹855.00 Million | 5.4% |
| Accounts Receivable | ₹5.51 Billion | 8.1% |
| Inventory | ₹1.55 Billion | 2.3% |
| Property, Plant & Equipment | ₹40.03 Billion | 58.9% |
| Intangible Assets | ₹303.00 Million | 0.5% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2010–2025)
This chart illustrates how Syngene International Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Syngene International Limited's current assets represent 33.7% of total assets in 2025, an increase from 13.6% in 2010.
- Cash Position: Cash and equivalents constituted 5.4% of total assets in 2025, up from 1.3% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2010.
- Asset Diversification: The largest asset category is property, plant & equipment at 58.9% of total assets.
Syngene International Limited Competitors by Total Assets
Key competitors of Syngene International Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Syngene International Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Syngene International Limited generates 0.54x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Syngene International Limited generates $7.30 in net profit.
Syngene International Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.72 | 1.99 | 1.52 |
| Quick Ratio | 1.56 | 1.81 | 1.47 |
| Cash Ratio | 0.27 | 0.23 | 0.00 |
| Working Capital | ₹8.59 Billion | ₹ 9.36 Billion | ₹ 6.51 Billion |
Syngene International Limited - Advanced Valuation Insights
This section examines the relationship between Syngene International Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.34 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 10.5% |
| Total Assets | ₹67.96 Billion |
| Market Capitalization | $834.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Syngene International Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Syngene International Limited's assets grew by 10.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Syngene International Limited (2010–2025)
The table below shows the annual total assets of Syngene International Limited from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹67.96 Billion | +10.47% |
| 2024-03-31 | ₹61.52 Billion | +5.50% |
| 2023-03-31 | ₹58.31 Billion | +4.80% |
| 2022-03-31 | ₹55.64 Billion | +13.94% |
| 2021-03-31 | ₹48.83 Billion | +17.30% |
| 2020-03-31 | ₹41.63 Billion | +12.40% |
| 2019-03-31 | ₹37.03 Billion | +16.13% |
| 2018-03-31 | ₹31.89 Billion | +14.97% |
| 2017-03-31 | ₹27.74 Billion | +16.08% |
| 2016-03-31 | ₹23.89 Billion | +68.10% |
| 2015-03-31 | ₹14.21 Billion | +19.36% |
| 2014-03-31 | ₹11.91 Billion | +64.44% |
| 2013-03-31 | ₹7.24 Billion | +23.46% |
| 2012-03-31 | ₹5.87 Billion | +16.37% |
| 2011-03-31 | ₹5.04 Billion | -1.54% |
| 2010-03-31 | ₹5.12 Billion | -- |